Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Sat, 03 Dec 16 04:36:45 +0000 Sat, 03 Dec 16 04:36:45 +0000 FDA Expands Jardiance Indication http://www.pharmacytimes.com/product-news/fda-expands-jardiance-indication http://www.pharmacytimes.com/product-news/fda-expands-jardiance-indication The FDA has approved a new indication for Boehringer Ingelheim&rsquo;s empagliflozin (Jardiance), allowing it to be used to reduce the risk of cardiovascular death in adult patients with type 2 diabetes and cardiovascular disease. Fri, 02 Dec 16 19:12:38 +0000 Will MDMA Be Legalized for PTSD Treatment? http://www.pharmacytimes.com/news/will-mdma-be-legalized-for-ptsd-treatment http://www.pharmacytimes.com/news/will-mdma-be-legalized-for-ptsd-treatment MDMA, better known as ecstasy or &ldquo;Molly&rdquo; and 3,4-methylenedioxymethamphetamine, is predominantly dismissed as an illicit street drug abused by raucous club-goers. Fri, 02 Dec 16 13:00:57 +0000 Veltassa Receives Label Change Approval http://www.pharmacytimes.com/product-news/veltassa-receives-label-change-approval http://www.pharmacytimes.com/product-news/veltassa-receives-label-change-approval The FDA has approved Relypsa, Inc.&rsquo;s supplemental New Drug Application (sNDA) with label updates of Veltassa (patiromer) for oral suspension. Veltassa was approved by the FDA for the treatment of hyperkalemia on October 21, 2015. Thu, 01 Dec 16 13:57:51 +0000 Potential Alzheimer's Treatment Falls Short in Phase 3 Trial http://www.pharmacytimes.com/product-news/potential-alzheimers-treatment-falls-short-in-phase-3-trial http://www.pharmacytimes.com/product-news/potential-alzheimers-treatment-falls-short-in-phase-3-trial A study that evaluated a phase 3 monoclonal antibody treatment that targeted Alzheimer&rsquo;s disease, solanezumab (Eli Lilly), did not meet its primary endpoint in the EXPEDITION3 clinical trial, according to a statement from the company. Thu, 01 Dec 16 12:00:59 +0000 FluLaval Quadrivalent Receives Expanded Indication http://www.pharmacytimes.com/product-news/flulaval-quadrivalent-receives-expanded-indication http://www.pharmacytimes.com/product-news/flulaval-quadrivalent-receives-expanded-indication Officials with GlaxoSmithKline have received approval from the FDA&rsquo;s Center for Biologics Evaluation and Research to expand the indication for FluLaval Quadrivalent to include use in children aged 6 months and older. Wed, 30 Nov 16 13:00:32 +0000 Independent Pharmacy Ownership Provides an Attractive Career Choice http://www.pharmacytimes.com/news/independent-pharmacy-ownership-provides-an-attractive-career-choice http://www.pharmacytimes.com/news/independent-pharmacy-ownership-provides-an-attractive-career-choice As a pharmacy student assessing career options, you may think that employment with one of the major chains is the best, or even the only, viable path. Tue, 29 Nov 16 20:10:47 +0000 Ajanta Launches Generic Abilify in US Market http://www.pharmacytimes.com/product-news/ajanta-launches-generic-abilify-in-us-market http://www.pharmacytimes.com/product-news/ajanta-launches-generic-abilify-in-us-market Ajanta has launched&nbsp;aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States. Tue, 29 Nov 16 12:00:43 +0000 Contour Next One Gets FDA Nod http://www.pharmacytimes.com/product-news/contour-next-one-gets-fda-nod http://www.pharmacytimes.com/product-news/contour-next-one-gets-fda-nod Officials with Ascensia Diabetes Care have announced that the Contour Next One Blood Glucose Monitoring System has received FDA 510(k) clearance. Mon, 28 Nov 16 12:00:53 +0000 Efficacy of Solithromycin Outweighs the Treatment Risks of Community-Acquired Bacterial Pneumonia http://www.pharmacytimes.com/product-news/efficacy-of-solithromycin-outweighs-the-treatment-risks-of-communityacquired-bacterial-pneumonia http://www.pharmacytimes.com/product-news/efficacy-of-solithromycin-outweighs-the-treatment-risks-of-communityacquired-bacterial-pneumonia The FDA Antimicrobial Drugs Advisory Committee (AMDAC) has voted 7-6 that the efficacy&nbsp;results of Cempra&#39;s solithromycin outweigh the risks for the treatment of community-acquired bacterial pneumonia (CABP). Thu, 24 Nov 16 12:00:36 +0000 Essure Receives New Boxed Warning and Patient Decision Checklist http://www.pharmacytimes.com/product-news/essure-receives-new-boxed-warning-and-patient-decision-checklist http://www.pharmacytimes.com/product-news/essure-receives-new-boxed-warning-and-patient-decision-checklist Following reports of pain and other adverse events, Essure, the permanently implanted birth control device for women from Bayer, now includes a new boxed warning and a Patient Decision Checklist.<br /> &nbsp; Wed, 23 Nov 16 12:00:55 +0000 5 New FDA Approvals to Know from October 2016 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-october-2016 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-october-2016 Learn about the new products and expanded indications approved by the FDA in October 2016.<br /> &nbsp; Tue, 22 Nov 16 21:42:17 +0000 FDA Green Lights Soliqua 100/33 for Type 2 Diabetes http://www.pharmacytimes.com/product-news/fda-green-lights-soliqua-10033-for-type-2-diabetes http://www.pharmacytimes.com/product-news/fda-green-lights-soliqua-10033-for-type-2-diabetes The FDA has approved Sanofi&rsquo;s once-daily Soliqua 100/33 (insulin glargine and lixisenatide injection) for the treatment of adults with type 2 diabetes. Tue, 22 Nov 16 15:50:07 +0000 FDA Approves NDA For Xultophy 100/3.6 for Type 2 Diabetes http://www.pharmacytimes.com/product-news/fda-approves-nda-for-xultophy-10036-for-type-2-diabetes http://www.pharmacytimes.com/product-news/fda-approves-nda-for-xultophy-10036-for-type-2-diabetes The FDA has approved the new drug application for Novo Nordisk&rsquo;s Xultophy 100/3.6 as an adjunct to diet and exercise in adults with type 2 diabetes. Tue, 22 Nov 16 15:44:06 +0000 Police Investigate Pharmacy Robberies Involving Syringe Possibly Containing HIV http://www.pharmacytimes.com/news/police-investigate-pharmacy-robberies-involving-syringe-possibly-containing-hiv http://www.pharmacytimes.com/news/police-investigate-pharmacy-robberies-involving-syringe-possibly-containing-hiv Police reported 2 instances of pharmacy robberies involving a man and woman wielding hypodermic needles that they claimed were contaminated with HIV.<br /> &nbsp; Tue, 22 Nov 16 14:31:29 +0000 FDA Mouse Model to Accelerate Zika Virus Research and Vaccine Development http://www.pharmacytimes.com/news/fda-mouse-model-to-accelerate-zika-virus-research-and-vaccine-development http://www.pharmacytimes.com/news/fda-mouse-model-to-accelerate-zika-virus-research-and-vaccine-development Although potential Zika virus vaccine candidates have shown promise in their early stages, emerging cases of the virus spreading throughout the United States have created urgency for the development of vaccination and therapeutic options. Tue, 22 Nov 16 13:39:55 +0000 Ajanta Launches Antifungal Drug Voriconazole http://www.pharmacytimes.com/product-news/ajanta-launches-antifungal-drug-voriconazole- http://www.pharmacytimes.com/product-news/ajanta-launches-antifungal-drug-voriconazole- Ajanta has launched&nbsp;voriconazole tablets in 50-mg and 200-mg doses in the US market. These tablets are the equivalent generic version of Vfend, an antifungal drug from Pfizer.<br /> &nbsp; Mon, 21 Nov 16 12:00:21 +0000 Antibody Neutralizes 98 Percent of HIV Strains http://www.pharmacytimes.com/news/antibody-neutralizes-98-percent-of-hiv-strains http://www.pharmacytimes.com/news/antibody-neutralizes-98-percent-of-hiv-strains Researchers have identified an antibody that can neutralize 98% of HIV strains, and may serve as a potential candidate for future HIV treatment and prevention. Fri, 18 Nov 16 22:31:38 +0000 What Losing the Affordable Care Act Means to Us: Women and Reproductive Health http://www.pharmacytimes.com/news/what-losing-the-affordable-care-act-means-to-us-women-and-reproductive-health http://www.pharmacytimes.com/news/what-losing-the-affordable-care-act-means-to-us-women-and-reproductive-health Testimony from women at different stages of life highlights the uncertainty of women&rsquo;s healthcare without the Affordable Care Act. Fri, 18 Nov 16 22:23:07 +0000 5 Must-See Sessions of ASHP 2016 http://www.pharmacytimes.com/news/5-cantmiss-sessions-of-ashp-2016 http://www.pharmacytimes.com/news/5-cantmiss-sessions-of-ashp-2016 The holidays are just around the corner, but that&rsquo;s not the only exciting thing about this time of year. ASHP&rsquo;s 2016 Midyear Clinical Meeting is coming up, and <em>Pharmacy Times</em> will be there to cover it. Fri, 18 Nov 16 19:57:15 +0000 Allergan Launches Taytulla, a Soft Gel Capsule Oral Contraceptive http://www.pharmacytimes.com/product-news/allergan-launches-taytulla-a-soft-gel-capsule-oral-contraceptive http://www.pharmacytimes.com/product-news/allergan-launches-taytulla-a-soft-gel-capsule-oral-contraceptive Allergan has launched Taytulla, an estrogen/progestin combination oral contraceptive, in a 1-mg/20-mg capsule form. Fri, 18 Nov 16 12:00:03 +0000 Precision-Medicine Could Improve Rheumatoid Arthritis Treatment http://www.pharmacytimes.com/news/precisionmedicine-could-improve-rheumatoid-arthritis-treatment http://www.pharmacytimes.com/news/precisionmedicine-could-improve-rheumatoid-arthritis-treatment New research is continuously identifying the underlying mechanisms of inflammatory arthritis, which leads to better understanding of the disease and new treatments. Thu, 17 Nov 16 22:27:54 +0000 FDA Approves Postmenopausal Dyspareunia Treatment http://www.pharmacytimes.com/product-news/fda-approves-postmenopausal-dyspareunia-treatment http://www.pharmacytimes.com/product-news/fda-approves-postmenopausal-dyspareunia-treatment The FDA has approved Endoceutics&#39; prasterone (Intrarosa), a once-daily vaginal insert for the treatment of women who experience moderate to severe pain during sexual intercourse as a result of menopause. Thu, 17 Nov 16 16:42:56 +0000 Janssen and Onyx Collaborate to Study Darzalex for Cancer Treatment http://www.pharmacytimes.com/product-news/janssen-and-onyx-collaborate-to-study-darzalex-for-cancer-treatment http://www.pharmacytimes.com/product-news/janssen-and-onyx-collaborate-to-study-darzalex-for-cancer-treatment Janssen has entered&nbsp;a clinical trial collaboration and supply agreement with Onyx to evaluate the efficacy and safety of Darzalex, &nbsp;the first-in-class CD38-directed immunotherapy daratumumab, in combination with a proteasome inhibitor carfilzomib and dexamethasone.<br /> &nbsp; Thu, 17 Nov 16 12:00:41 +0000 Baricitinib Shows Early Response, Improved Patient-Reported Outcomes in Rheumatoid Arthritis http://www.pharmacytimes.com/news/baricitinib-shows-early-response-improved-patientreported-outcomes-in-rheumatoid-arthritis http://www.pharmacytimes.com/news/baricitinib-shows-early-response-improved-patientreported-outcomes-in-rheumatoid-arthritis A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira). Wed, 16 Nov 16 16:51:38 +0000 New Jersey Pharmacists Charged in Illegal Opioid Distribution Scheme http://www.pharmacytimes.com/news/new-jersey-pharmacists-charged-in-illegal-opioid-distribution-scheme http://www.pharmacytimes.com/news/new-jersey-pharmacists-charged-in-illegal-opioid-distribution-scheme Two pharmacists are being accused for their roles in a long-running, illegal prescription pain medication distribution conspiracy. Wed, 16 Nov 16 13:00:45 +0000